Challenges of Getting Accurate Spend Projections - HLS, Biotech, Cannabis
GURUS Cloud Connect
Let’s face it - no company can afford errors or discrepancies when it comes to spend projections.
For companies within industries that demand a high level of data scrutiny and accuracy in their spend projections and investor reports, such as Health Science companies, Biotech, Clinical Trials, Cannabis, and Pharma, adapting newer cloud-based tools is essential for streamlining their projection process, and ensuring there are no errors along the way.
In this snippet from GURUS Cloud Connect’s Planning and Budgeting episode, GURUS technical consultant, Matthew Jay, teaches you how to get accurate projections and overcome unnecessary risks for public companies.